Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 27;16(5):e0010463.
doi: 10.1371/journal.pntd.0010463. eCollection 2022 May.

Performance of a rapid immuno-chromatographic test (Schistosoma ICT IgG-IgM) for detecting Schistosoma-specific antibodies in sera of endemic and non-endemic populations

Affiliations

Performance of a rapid immuno-chromatographic test (Schistosoma ICT IgG-IgM) for detecting Schistosoma-specific antibodies in sera of endemic and non-endemic populations

Julie Hoermann et al. PLoS Negl Trop Dis. .

Abstract

Background: Schistosomiasis, an acute and chronic parasitic disease caused by human pathogenic Schistosoma species, is a neglected tropical disease affecting more than 220 million people worldwide. For diagnosis of schistosomiasis, stool and urine microscopy for egg detection is still the recommended method, however sensitivity of these methods is limited. Therefore, other methods like molecular detection of DNA in stool, detection of circulating cathodic antigen in urine or circulating anodic antigen in urine and serum, as well as serological tests have gained more attention. This study examines the sensitivity and specificity of a rapid diagnostic test based on immunochromatography (Schistosoma ICT IgG-IgM, LD Bio, Lyon, France) for simultaneous detection of specific IgG and IgM antibodies in serum, against Schistosoma spp. in endemic and non-endemic populations.

Methodology/principal findings: Frozen banked serum samples from patients with confirmed schistosomiasis, patients with other helminth infections, patients with seropositive rheumatoid arthritis and healthy blood donors were used to assess the sensitivity and the specificity of the Schistosoma ICT IgG-IgM rapid diagnostic test. The test showed a sensitivity of 100% in patients with parasitologically confirmed schistosomiasis, irrespective of the species (S. mansoni, S. haematobium, S. japonicum, S. mekongi). In healthy blood donors and patients with rheumatoid factor positive rheumatoid arthritis from Europe, specificity was 100%. However, in serum samples of patients with other tissue invasive helminth infections, the test showed some cross-reactivity, resulting in a specificity of 85%.

Conclusion/significance: With its high sensitivity, the Schistosoma ICT IgG-IgM rapid diagnostic test is a suitable screening test for detection of Schistosoma specific antibodies, including S. mekongi. However, in populations with a high prevalence of co-infection with other tissue invasive helminths, positive results should be confirmed with other diagnostic assays due to the test's imperfect specificity.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Schistosoma spp. (n = 74), tissue helminth (n = 80) and blood donor (n = 20) sera. OD 492 values of Adult antigen ELISA (AWE) and egg antigen ELISA (SEA) plotted for serum panels with ICT IgG-IgM POC negative and positive results.
ELISA (AWE) OD < 0.15 negative, OD 0.15–0.29 inconclusive, OD ≥ 0.3 positive. ELISA (SEA) OD < 0.3 negative, OD 0.3–0.59 inconclusive, OD ≥ 0.6 positive. Dotted lines show the two cutoff values of the ELISAs.

Similar articles

Cited by

References

    1. DALYs GBD, Collaborators H. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390: 1260–1344. doi: 10.1016/S0140-6736(17)32130-X - DOI - PMC - PubMed
    1. World Health Organisation (WHO). Factsheet Schistosomiasis. 2021. 02/03/2020 [cited 2021 01/26/2021]; Available from: https://www.who.int/en/news-room/fact-sheets/detail/schistosomiasis.
    1. Colley DG, Bustinduy AL, Secor WE, King CH. Human schistosomiasis. Lancet. 2014; 383: 2253–64. doi: 10.1016/S0140-6736(13)61949-2 - DOI - PMC - PubMed
    1. Beltrame A, Guerriero M, Angheben A, Gobbi F, Requena-Mendez A, Zammarchi L, et al.. Accuracy of parasitological and immunological tests for the screening of human schistosomiasis in immigrants and refugees from African countries: An approach with Latent Class Analysis. PLoS Negl Trop Dis. 2017; 11: e0005593. doi: 10.1371/journal.pntd.0005593 - DOI - PMC - PubMed
    1. Weerakoon KG, Gobert GN, Cai P, McManus DP. Advances in the Diagnosis of Human Schistosomiasis. Clin Microbiol Rev. 2015; 28: 939–67. doi: 10.1128/CMR.00137-14 - DOI - PMC - PubMed